We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRRO icon
12251
PUT
Korro Bio
KRRO
$196M
$153K ﹤0.01%
432
-588
-58% -$231K
MTA
12252
Metalla Royalty & Streaming
MTA
$912M
$153K ﹤0.01%
22,439
-18,592
-45% -$143K
LBC
12253
DELISTED
Luther Burbank Corporation Common Stock
LBC
$153K ﹤0.01%
11,468
-17,609
-61% -$224K
ACOR
12254
PUT
DELISTED
Acorda Therapeutics
ACOR
$153K ﹤0.01%
1,660
+645
+64% +$53.5K
CLAS.WS
12255
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$153K ﹤0.01%
260,897
+85,677
+49% +$61.8K
BHR
12256
Braemar Hotels & Resorts
BHR
$139M
$152K ﹤0.01%
31,326
-215,324
-87% -$1.12M
CANE icon
12257
Teucrium Sugar Fund
CANE
$53.5M
$152K ﹤0.01%
15,877
-24,087
-60% -$219K
SLI
12258
Standard Lithium
SLI
$587M
$152K ﹤0.01%
+18,691
New +$123K
STEW
12259
SRH Total Return Fund
STEW
$1.79B
$152K ﹤0.01%
+11,574
New +$158K
DMK
12260
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$152K ﹤0.01%
2,234
+1,174
+111% +$85.9K
DTEA
12261
PUT
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$152K ﹤0.01%
60,600
-2,500
-4% -$8.79K
LMACA
12262
PUT
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$152K ﹤0.01%
+15,100
New +$153K
DMYQ.WS
12263
DELISTED
dMY Technology Group, Inc. IV Redeemable warrants, each whole warrant exercisable for one share of C
DMYQ.WS
$152K ﹤0.01%
80,177
-122,944
-61% -$194K
ASPS icon
12264
PUT
Altisource Portfolio Solutions
ASPS
$64.4M
$151K ﹤0.01%
+1,913
New +$142K
LODE icon
12265
CALL
Comstock
LODE
$263M
$151K ﹤0.01%
5,670
-14,050
-71% -$421K
NUVB icon
12266
CALL
Nuvation Bio
NUVB
$2.18B
$151K ﹤0.01%
+15,200
New +$138K
SLAMW
12267
DELISTED
Slam Corp. warrant
SLAMW
$151K ﹤0.01%
168,207
+76,334
+83% +$81.7K
VIA
12268
CALL
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$151K ﹤0.01%
2,960
+700
+31% +$38.8K
WMC
12269
PUT
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$151K ﹤0.01%
5,790
-1,330
-19% -$37.9K
AVEO
12270
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$151K ﹤0.01%
24,400
-6,900
-22% -$41.3K
BMRA icon
12271
CALL
Biomerica
BMRA
$4.88M
$150K ﹤0.01%
4,163
+775
+23% +$25.5K
DRD
12272
CALL
DRDGold
DRD
$2.1B
$150K ﹤0.01%
+18,600
New +$179K
KT icon
12273
PUT
KT
KT
$9.11B
$150K ﹤0.01%
11,000
-21,200
-66% -$300K
LSTA icon
12274
CALL
Lisata Therapeutics
LSTA
$9.82M
$150K ﹤0.01%
8,213
-2,514
-23% -$49.3K
PGRE
12275
CALL
DELISTED
Paramount Group
PGRE
$150K ﹤0.01%
16,700
+5,300
+46% +$49.1K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.